Three Blood Biomarkers Predict Higher Risk of Heart Attack, Stroke in Women

Translate to Spanish or other 102 languages!

Three blood biomarkers could help predict heart attack and stroke risk in women. Image for illustration purposes
Three blood biomarkers could help predict heart attack and stroke risk in women. Image for illustration purposes
- Advertisement -
  • Cardiovascular disease is the leading cause of death in women globally. 
  • There have historically been disparities in diagnosing cardiovascular disease in women as they may have no or different symptoms than men. 
  • Researchers from Brigham and Women’s Hospital found measuring three different biological blood markers can better predict a woman’s risk of having a major cardiovascular event over the next 30 years compared to measuring only one biomarker.

Cardiovascular disease is the leading cause of death in women around the globe, while stroke is the third most commonTrusted Source.

Follow the link to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/3-blood-biomarkers-predict-higher-risk-of-heart-attack-stroke-in-women?slot_pos=article_2&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-09-11&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

South Padre Island Steps Up for Breast Cancer Awareness at 2026 Walk for Women, Oct. 4th

South Padre Island will come together in a show of hope, strength and support on Sunday, October 4, for the annual Walk for Breast Cancer Awareness, benefiting South Padre Island’s Walk for Women and its mission to help Rio Grande Valley women and families affected by breast cancer.

DHR Health Offers Mammogram Screening Special During “Breast Cancer Awareness Month”

October is “Breast Cancer Awareness Month,” and DHR Health is encouraging women to prioritize their breast health by offering their annual mammogram screening special.

FDA Approves First Treatment for MCT8 Deficiency

The U.S. Food and Drug Administration approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid heart rate, increased blood pressure and adverse effects on metabolism) in patients with MCT8 deficiency, also known as Allan-Herndon-Dudley syndrome.

Insomnia Linked to a Higher Risk of Stroke

 Insomnia is not only associated with poor sleep and reduced daytime functioning, but may also be an indicator of increased health risks. An international review by the European Academy of Neurology, in collaboration with MedUni Vienna, shows a link to stroke, hospital admissions and several neurological and mental health conditions. The findings were published in the high ranking journal “Sleep Medicine Reviews”.
- Advertisement -